Polymyxin B vs Teixobactin — mechanism, half-life, dosing, and research status compared. Which is right for your protocol?
Polymyxin B is a cyclic lipopeptide antibiotic from Bacillus polymyxa that was approved in the 1960s and fell out of favor due to nephrotoxicity, but has experienced a major clinical resurgence as a last-resort treatment for carbapenem-resistant Gram-negative infections (Acinetob...
Calculate Polymyxin B dose →Teixobactin was reported in Nature in 2015 as the first new antibiotic class discovered in 30 years, isolated from uncultured soil bacteria Eleftheria terrae using the iChip (isolation chip) technology that allows cultivation of previously unculturable organisms. Teixobactin bind...
Calculate Teixobactin dose →| Parameter | Polymyxin B | Teixobactin |
|---|---|---|
| Category | Antimicrobial Peptide | Antimicrobial Peptide |
| Research | FDA Approved | Preclinical |
| Half-Life | 6-8 hours | Hours (in vivo) |
| Typical Dose | 15,000-25,000 units/kg/day IV | N/A |
| Frequency | Every 12 hours IV | N/A |
| Route | IV / IM / Topical / Intrathecal | Research only (IV in animal studies) |
| FDA Status | Approved (systemic Gram-negative infections) | Not approved (preclinical) |
Use ASCEND's free reconstitution calculator to get exact syringe draw amounts for your vial.
For research use only. Not medical advice. ASCEND does not conduct or endorse any specific research protocol. Always consult relevant scientific literature and regulatory guidelines.